Viraj Dhirubhai Shah
About Viraj Dhirubhai Shah
Data last updated:
Viraj Dhirubhai Shah is a Director at Raptim Research Private Limited (since 2009), Designated Partner at Citus Research Llp (since 2018) and Director at Nova Chemdrugs Private Limited (since 2015). The companies operate in Life Sciences, Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹172 Cr; the largest is Raptim Research Private Limited at ₹146 Cr (FY 2025). Earlier, Viraj Dhirubhai Shah was a Director at Accela Pharmaceuticals Private Limited (2010–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Raptim Research Private Limited U73100MH2002PTC136230 | Director | 10 Apr 2009 | 2002 | ₹146 Cr (FY 2025) | Active |
 Citus Research Llp AAN-3437 | Designated Partner | 25 Sep 2018 | 2018 | ₹22.91 Cr (FY 2023) | Active |
 Nova Chemdrugs Private Limited U24232MH2001PTC108616 | Director | 15 Oct 2015 | 2001 | ₹3.09 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Accela Pharmaceuticals Private Limited U24232PN2010PTC136759 | Director | 10 Nov 2010 | 2010 | ₹10 Lakh (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Viraj Dhirubhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Meghana Rajen Shah | 10377931 | Raptim Research Private Limited , Nova Chemdrugs Private Limited | Director |
| Rajen Dhirubhai Shah | 00051964 | Raptim Research Private Limited , Citus Research Llp and 1 more | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Viraj Dhirubhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viraj Dhirubhai Shah
Viraj Dhirubhai Shah currently holds 3 directorships: Raptim Research Private Limited (Director, since 10 Apr 2009, revenue ₹146 Cr (FY 2025)); Citus Research Llp (Designated Partner, since 25 Sep 2018, revenue ₹22.91 Cr (FY 2023)); Nova Chemdrugs Private Limited (Director, since 15 Oct 2015, revenue ₹3.09 Cr (FY 2025)).
Viraj Dhirubhai Shah was first appointed on 10 Apr 2009 as Director at Raptim Research Private Limited. The most recent appointment on record is 25 Sep 2018 at Citus Research Llp.
The 3 current companies of Viraj Dhirubhai Shah that report revenue have a combined latest revenue of ₹172 Cr: Raptim Research Private Limited ₹146 Cr (FY 2025); Citus Research Llp ₹22.91 Cr (FY 2023); Nova Chemdrugs Private Limited ₹3.09 Cr (FY 2025).
Viraj Dhirubhai Shah held 1 earlier board appointment: Accela Pharmaceuticals Private Limited (Director, 10 Nov 2010 to 19 Apr 2022).
The current boards of Viraj Dhirubhai Shah's companies include Meghana Rajen Shah (Raptim Research Private Limited), Rajen Dhirubhai Shah (Raptim Research Private Limited).